| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Aortic Valve Stenosis | 10 | 2018 | 741 | 2.10 | Why? |
| Transcatheter Aortic Valve Replacement | 10 | 2018 | 839 | 1.73 | Why? |
| Aneurysm, False | 3 | 2018 | 88 | 1.39 | Why? |
| Aortic Valve | 6 | 2018 | 664 | 1.29 | Why? |
| Foramen Ovale, Patent | 2 | 2019 | 153 | 1.23 | Why? |
| Heart-Assist Devices | 6 | 2019 | 812 | 1.17 | Why? |
| Cardiac Catheterization | 4 | 2020 | 882 | 1.12 | Why? |
| Heart Valve Prosthesis Implantation | 4 | 2017 | 552 | 1.07 | Why? |
| Acute Coronary Syndrome | 3 | 2020 | 2107 | 0.87 | Why? |
| Radial Artery | 3 | 2018 | 132 | 0.86 | Why? |
| Myocardial Infarction | 5 | 2020 | 3361 | 0.84 | Why? |
| Intra-Aortic Balloon Pumping | 2 | 2018 | 125 | 0.84 | Why? |
| Catheterization, Peripheral | 3 | 2018 | 249 | 0.83 | Why? |
| Aortic Valve Insufficiency | 2 | 2017 | 136 | 0.76 | Why? |
| Axillary Artery | 1 | 2018 | 16 | 0.74 | Why? |
| Mitral Valve Stenosis | 1 | 2018 | 29 | 0.73 | Why? |
| Embolism, Paradoxical | 1 | 2018 | 22 | 0.73 | Why? |
| Pericarditis | 2 | 2015 | 417 | 0.72 | Why? |
| Limb Deformities, Congenital | 1 | 2017 | 35 | 0.70 | Why? |
| Attitude to Computers | 1 | 2018 | 126 | 0.69 | Why? |
| Shock, Cardiogenic | 4 | 2019 | 700 | 0.68 | Why? |
| Heart Valve Prosthesis | 6 | 2018 | 533 | 0.68 | Why? |
| Patient Selection | 4 | 2019 | 4560 | 0.67 | Why? |
| Heart Aneurysm | 1 | 2017 | 46 | 0.67 | Why? |
| Scholarly Communication | 1 | 2018 | 123 | 0.63 | Why? |
| Telemetry | 1 | 2018 | 240 | 0.62 | Why? |
| Percutaneous Coronary Intervention | 5 | 2021 | 3646 | 0.60 | Why? |
| Esophagus | 1 | 2017 | 139 | 0.60 | Why? |
| Postoperative Hemorrhage | 1 | 2017 | 183 | 0.59 | Why? |
| Prosthesis Implantation | 1 | 2018 | 261 | 0.59 | Why? |
| Absorbable Implants | 1 | 2017 | 191 | 0.56 | Why? |
| Spine | 1 | 2017 | 292 | 0.56 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2017 | 161 | 0.55 | Why? |
| Anal Canal | 1 | 2017 | 367 | 0.54 | Why? |
| Pulmonary Infarction | 1 | 2013 | 28 | 0.52 | Why? |
| Cardiologists | 1 | 2018 | 366 | 0.51 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.49 | Why? |
| Endocarditis | 1 | 2018 | 368 | 0.49 | Why? |
| Trachea | 1 | 2017 | 894 | 0.48 | Why? |
| Pulmonary Embolism | 3 | 2020 | 4775 | 0.45 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.45 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.43 | Why? |
| Monitoring, Physiologic | 2 | 2018 | 1956 | 0.42 | Why? |
| Echocardiography, Doppler, Color | 3 | 2017 | 114 | 0.37 | Why? |
| Echocardiography | 3 | 2018 | 3661 | 0.35 | Why? |
| Heart Defects, Congenital | 1 | 2017 | 933 | 0.35 | Why? |
| Risk Assessment | 6 | 2021 | 25439 | 0.35 | Why? |
| Hemodynamics | 5 | 2019 | 1562 | 0.35 | Why? |
| Device Approval | 2 | 2017 | 93 | 0.32 | Why? |
| Vascular Access Devices | 2 | 2018 | 122 | 0.32 | Why? |
| Stroke | 4 | 2021 | 8839 | 0.31 | Why? |
| Postoperative Complications | 4 | 2018 | 5861 | 0.30 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.30 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.28 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.28 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.25 | Why? |
| District of Columbia | 3 | 2017 | 343 | 0.23 | Why? |
| Autoimmune Diseases | 1 | 2015 | 1996 | 0.22 | Why? |
| Treatment Outcome | 15 | 2021 | 51732 | 0.22 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.22 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.21 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.21 | Why? |
| Contraindications, Drug | 1 | 2021 | 281 | 0.21 | Why? |
| Social Media | 2 | 2020 | 5798 | 0.21 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.20 | Why? |
| Electrocardiography | 2 | 2017 | 3957 | 0.20 | Why? |
| Femoral Artery | 2 | 2018 | 213 | 0.20 | Why? |
| Coronary Angiography | 3 | 2018 | 2275 | 0.19 | Why? |
| Palpation | 1 | 2018 | 16 | 0.19 | Why? |
| Recurrence | 3 | 2021 | 3675 | 0.18 | Why? |
| Cardiovascular Diseases | 3 | 2018 | 11497 | 0.18 | Why? |
| Radionuclide Ventriculography | 1 | 2017 | 4 | 0.18 | Why? |
| Clinical Trials as Topic | 2 | 2017 | 7330 | 0.18 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.18 | Why? |
| Humans | 43 | 2021 | 930598 | 0.18 | Why? |
| Prosthesis Design | 2 | 2019 | 594 | 0.18 | Why? |
| Replantation | 1 | 2017 | 8 | 0.18 | Why? |
| Aortography | 1 | 2017 | 60 | 0.17 | Why? |
| Bundle-Branch Block | 1 | 2018 | 127 | 0.16 | Why? |
| Echocardiography, Transesophageal | 2 | 2017 | 447 | 0.16 | Why? |
| Prostheses and Implants | 1 | 2017 | 116 | 0.16 | Why? |
| Ultrasonography, Interventional | 2 | 2018 | 560 | 0.15 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Bioprosthesis | 1 | 2017 | 126 | 0.15 | Why? |
| Brugada Syndrome | 1 | 2017 | 98 | 0.15 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.15 | Why? |
| Creatine Kinase, MB Form | 1 | 2017 | 259 | 0.15 | Why? |
| Male | 22 | 2021 | 367725 | 0.15 | Why? |
| Thrombin | 1 | 2018 | 325 | 0.14 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.14 | Why? |
| Hematoma | 1 | 2018 | 305 | 0.14 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 396 | 0.14 | Why? |
| Time Factors | 7 | 2019 | 31397 | 0.13 | Why? |
| Hospitals, High-Volume | 1 | 2017 | 688 | 0.13 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2021 | 3051 | 0.13 | Why? |
| Non-ST Elevated Myocardial Infarction | 1 | 2019 | 490 | 0.13 | Why? |
| Risk Factors | 10 | 2021 | 71621 | 0.13 | Why? |
| Access to Information | 1 | 2018 | 483 | 0.13 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.13 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.12 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.12 | Why? |
| Factor Xa Inhibitors | 1 | 2017 | 490 | 0.12 | Why? |
| Female | 21 | 2021 | 380317 | 0.12 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.11 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.11 | Why? |
| Troponin | 1 | 2017 | 1058 | 0.11 | Why? |
| Recovery of Function | 2 | 2019 | 2461 | 0.11 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.10 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.10 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.10 | Why? |
| Heart Arrest | 1 | 2021 | 1239 | 0.10 | Why? |
| Chest Pain | 1 | 2013 | 578 | 0.09 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.09 | Why? |
| Aged | 14 | 2021 | 215776 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Clinical Protocols | 1 | 2019 | 2734 | 0.09 | Why? |
| Health Communication | 1 | 2018 | 1120 | 0.08 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.08 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2021 | 1876 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.08 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.08 | Why? |
| Computed Tomography Angiography | 1 | 2017 | 2153 | 0.08 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.08 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.08 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.08 | Why? |
| Radiography | 1 | 2013 | 1576 | 0.07 | Why? |
| Follow-Up Studies | 3 | 2017 | 17020 | 0.07 | Why? |
| United States | 7 | 2021 | 46150 | 0.07 | Why? |
| Mortality | 2 | 2018 | 7132 | 0.07 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Atrial Fibrillation | 2 | 2017 | 2320 | 0.06 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.06 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Acute Disease | 1 | 2015 | 6029 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.06 | Why? |
| Cardiology | 1 | 2016 | 2873 | 0.06 | Why? |
| Adult | 5 | 2021 | 244371 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Dyspnea | 1 | 2013 | 3847 | 0.05 | Why? |
| Punctures | 1 | 2018 | 89 | 0.05 | Why? |
| Hemostatic Techniques | 1 | 2018 | 60 | 0.05 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.04 | Why? |
| Reoperation | 1 | 2021 | 544 | 0.04 | Why? |
| Balloon Valvuloplasty | 1 | 2018 | 49 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Cardiac Conduction System Disease | 1 | 2017 | 44 | 0.04 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| North America | 1 | 2021 | 1400 | 0.04 | Why? |
| Cardiac Pacing, Artificial | 1 | 2018 | 160 | 0.04 | Why? |
| Biomedical Research | 1 | 2016 | 5270 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2015 | 6153 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Retrospective Studies | 5 | 2018 | 105322 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Walk Test | 1 | 2018 | 461 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Registries | 3 | 2021 | 12327 | 0.03 | Why? |
| Michigan | 1 | 2018 | 988 | 0.03 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.03 | Why? |
| Tachycardia, Ventricular | 1 | 2017 | 251 | 0.03 | Why? |
| Multidetector Computed Tomography | 1 | 2017 | 307 | 0.03 | Why? |
| Pacemaker, Artificial | 1 | 2018 | 431 | 0.03 | Why? |
| Inflammation | 1 | 2015 | 13255 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2018 | 663 | 0.03 | Why? |
| Coronary Disease | 1 | 2017 | 645 | 0.03 | Why? |
| Patient Acuity | 1 | 2018 | 1755 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2017 | 1276 | 0.02 | Why? |
| Cohort Studies | 3 | 2017 | 36005 | 0.02 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Canada | 1 | 2021 | 6018 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| African Americans | 1 | 2017 | 3363 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |